Literature DB >> 9210705

In situ simultaneous detection of hepatitis C virus RNA and hepatitis C virus-related antigens in hepatocellular carcinoma.

D Sansonno1, V Cornacchiulo, V Racanelli, F Dammacco.   

Abstract

BACKGROUND: The overwhelming evidence that chronic infection with the hepatitis C virus (HCV) is an important cause of hepatocellular carcinoma (HCC) is based on epidemiologic, case-control, and cohort studies as well as laboratory investigations. To address better the pathogenesis of HCV infection at the single-cell level, the authors developed a specific reproducible method for the simultaneous detection of HCV specific sequences and antigens in liver tissue, using a combination of nonradioactive in situ hybridization and immunohistochemistry.
METHODS: After immunohistochemical staining of the liver sections for E2/NS-1, C22-3, C33c, C100-3, and NS-5 antigens with immunogold-silver technique, in situ hybridization was performed on the same sections using digoxigenin-labeled HCV 5' NonCoding specific probes. The hybridization signal was detected by an antidigoxigenin, Fab fragment-alkaline phosphatase conjugate. This simultaneous detection permitted the subcellular localization of HCV RNA and antigens with excellent preservation of tissue morphology and absence of background staining. In addition, the types and percentages of cells harboring HCV in tissue could be determined.
RESULTS: The in situ detection of HCV showed positive signals in both cancerous and noncancerous areas of liver tissue in six of six HCV-infected patients with HCC and in none of four controls, including three HCV negative HCC patients and one patient with epithelioid hemangioendothelioma. Two classes of infected cells were distinguished throughout the liver: (1) cells containing large amounts of negative-stranded HCV RNA, which were probably undergoing active viral replication; and (2) cells displaying positive-stranded HCV RNA only, with unpredictable levels of viral replication. Both types expressed core, envelope, and NS-3, -4, and -5 proteins. HCV RNA and antigens were exclusively cytoplasmic. Detection of viral proteins was highly predictive of the presence of large amounts of HCV RNA in the same cell. Fewer HCV positive cells were consistently demonstrated in the cancerous area.
CONCLUSIONS: These findings support the contention that HCV infects hepatocytes and replicates in them, even after their malignant transformation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9210705

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

1.  Localization of HCV RNA and capsid protein in human hepatocellular carcinoma.

Authors:  Yi-Ming Dai; Zhi-Ping Shou; Can-Rong Ni; Neng-Jin Wang; Song-Ping Zhang
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

2.  Structure analysis and expressions of a novel tetratransmembrane protein, lysosoma-associated protein transmembrane 4 beta associated with hepatocellular carcinoma.

Authors:  Xin-Rong Liu; Rou-Li Zhou; Qing-Yun Zhang; Ye Zhang; Yue-Ying Jin; Ming Lin; Jing-An Rui; Da-Xiong Ye
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

3.  In situ distribution of hepatitis C virus replicative-intermediate RNA in hepatic tissue and its correlation with liver disease.

Authors:  M Chang; A P Marquardt; B L Wood; O Williams; S J Cotler; S L Taylor; R L Carithers; D R Gretch
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Detection of hepatitis B and C viruses in almost all hepatocytes by modified PCR-based in situ hybridization.

Authors:  Hideko Nuriya; Kazuaki Inoue; Takeshi Tanaka; Yukiko Hayashi; Tsunekazu Hishima; Nobuaki Funata; Kyosuke Kaji; Seishu Hayashi; Shuichi Kaneko; Michinori Kohara
Journal:  J Clin Microbiol       Date:  2010-08-25       Impact factor: 5.948

5.  Transarterial chemoembolization plus sorafenib: a sequential therapeutic scheme for HCV-related intermediate-stage hepatocellular carcinoma: a randomized clinical trial.

Authors:  Domenico Sansonno; Gianfranco Lauletta; Sabino Russi; Vincenza Conteduca; Loredana Sansonno; Franco Dammacco
Journal:  Oncologist       Date:  2012-02-14

6.  Core protein-coding sequence, but not core protein, modulates the efficiency of cap-independent translation directed by the internal ribosome entry site of hepatitis C virus.

Authors:  T H Wang; R C Rijnbrand; S M Lemon
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 7.  Role of macrophages and monocytes in hepatitis C virus infections.

Authors:  Dennis Revie; Syed Zaki Salahuddin
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

8.  Role of the receptor for the globular domain of C1q protein in the pathogenesis of hepatitis C virus-related cryoglobulin vascular damage.

Authors:  Domenico Sansonno; Felicia Anna Tucci; Berhane Ghebrehiwet; Gianfranco Lauletta; Ellinor I B Peerschke; Vincenza Conteduca; Sabino Russi; Pietro Gatti; Loredana Sansonno; Franco Dammacco
Journal:  J Immunol       Date:  2009-10-14       Impact factor: 5.422

9.  Simultaneous detection of nucleic acid and protein using gold nanoparticles and lateral flow device.

Authors:  Xun Mao; Anant Gurung; Hui Xu; Meenu Baloda; Yuqing He; Guodong Liu
Journal:  Anal Sci       Date:  2014       Impact factor: 2.081

10.  Hepatitis C virus proteins modulate microRNA expression and chemosensitivity in malignant hepatocytes.

Authors:  Chiara Braconi; Nicola Valeri; Pierluigi Gasparini; Nianyuan Huang; Cristian Taccioli; Gerard Nuovo; Tetsuro Suzuki; Carlo Maria Croce; Tushar Patel
Journal:  Clin Cancer Res       Date:  2010-01-26       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.